Lipidomics: a promising cancer biomarker

Abstract The prevention, diagnosis and targeted therapies of cancer are important in cancer controlling and treatment. The present challenge about cancer biomarker still remains in identifying the special biomarkers for predicting cancer risk and assessing patient’s response during anticancer treatm...

Full description

Bibliographic Details
Main Authors: Furong Yan, Hong Zhao, Yiming Zeng
Format: Article
Language:English
Published: Wiley 2018-07-01
Series:Clinical and Translational Medicine
Subjects:
Online Access:http://link.springer.com/article/10.1186/s40169-018-0199-0
Description
Summary:Abstract The prevention, diagnosis and targeted therapies of cancer are important in cancer controlling and treatment. The present challenge about cancer biomarker still remains in identifying the special biomarkers for predicting cancer risk and assessing patient’s response during anticancer treatment. Lipidomics, in simple definition is the quantification of all lipids in a confined biological entity. Lipids play roles in membrane structure, energy storage, and signal transduction as well as in human cancers. Previous researches indicated that lipids may serve as a promising biomarker in the early diagnoses and individualized treatment of cancer.
ISSN:2001-1326